1. Home
  2. RNAC vs SMTI Comparison

RNAC vs SMTI Comparison

Compare RNAC & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cartesian Therapeutics Inc.

RNAC

Cartesian Therapeutics Inc.

HOLD

Current Price

$5.84

Market Cap

243.0M

Sector

Health Care

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$22.13

Market Cap

208.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNAC
SMTI
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
243.0M
208.8M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
RNAC
SMTI
Price
$5.84
$22.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
2
Target Price
$34.00
$34.00
AVG Volume (30 Days)
145.8K
39.7K
Earning Date
05-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
$2,797,000.00
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
N/A
$12.48
P/E Ratio
N/A
$442.40
Revenue Growth
N/A
32.47
52 Week Low
$5.60
$16.05
52 Week High
$14.56
$35.70

Technical Indicators

Market Signals
Indicator
RNAC
SMTI
Relative Strength Index (RSI) 39.56 54.87
Support Level N/A $18.20
Resistance Level $7.95 $24.17
Average True Range (ATR) 0.74 1.23
MACD -0.14 -0.20
Stochastic Oscillator 4.27 40.78

Price Performance

Historical Comparison
RNAC
SMTI

About RNAC Cartesian Therapeutics Inc.

Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: